Asia Pacific Hospital Bed Market

The hospital bed market in Asia Pacific is expected to grow from US$ 796.88 million in 2022 to US$ 1,178.64 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2022 to 2028. 

Home Healthcare Amenities for Geriatric Population and Postoperative Care 

Home healthcare (HHC) services range from nursing care to specialized medical services, involving laboratory work. As HHC is provided remotely, it is less expensive, and more convenient and effective than the care given in hospitals or expert nursing facilities. For example, the NITI Aayog report states that HHC services save ~15–30% on real estate and infrastructure compared to hospital expenses associated with similar treatment. Further, postoperative care is a critical part of the HHC, with many large hospitals offering an extensive continuum of care. For example, healthcare technology companies offer streamlined critical care at home with advanced facilities. Although the adoption of HHC services is in a relatively nascent stage in remote areas of APAC, it has tremendous potential for growth owing to rising geriatric population, increasing chronic disease incidence, seeking long-term care, and accelerating demand for constant personalized care that may not be provided in formal hospital settings. By 2050, 2 billion people would be at the age of 60, with 80% of them living in developing countries. With the high preference for HHC services among the geriatric population, the demand for hospital bed is likely to reach an all-time high soon. These factors are likely to accelerate the demand for hospital beds in the coming years. 

Market Overview 

Asia Pacific is the fastest-growing regional market for hospital beds. The Asia Pacific hospital bed market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific has accounted for a considerable market share of the hospital bed market in 2021, owing to the accelerated economic growth of many countries such as China and Japan, growing government focus on the healthcare sector, rising prevalence of chronic diseases, outbreak of COVID-19, investment from government bodies for expansion of healthcare facilities, and favorable regulatory reforms. These factors are expected to propel the Asia Pacific hospital bed market in the coming years. 

Asia Pacific Hospital Bed Market Revenue and Forecast to 2028 (US$ Million) 

Asia Pacific Hospital Bed Market Segmentation 

The Asia Pacific hospital bed market is segmented on the basis of type, usage, application, end user, and country. Based on type, the market is segmented into semi-electric bed, electric bed, and manual bed. The semi-electric bed segment held the largest market share in 2022. 

Based on usage, the market is segmented into acute care bed, long-term care bed, psychiatric care bed, and others. The acute care bed segment held the largest market share in 2022. Based on application, the market is bifurcated into non-intensive care bed and intensive care bed. The non-intensive care bed segment held a larger market share in 2022. Based on end user, the market is categorized into hospitals & clinics, elderly care facilities, ambulatory surgical centers, and home care settings. The hospitals & clinics segment held the largest market share in 2022. Based on country, the market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the market share in 2022. Hill Rom Holding inc. (Baxter); Stryker Corporation; Arjo Medical Devices; Invacare Corporation; Malvestio Spa; Paramount Bed Holdings Co., Ltd.; Savion Industries; and STIEGELMEYER GMBH AND CO.KG are among the leading companies operating in the Asia Pacific hospital bed market.

Asia Pacific Hospital Bed Market Strategic Insights

Asia Pacific Hospital Bed Market Segmentation Analysis

Asia Pacific Hospital Bed Market Report Highlights

Asia Pacific Hospital Bed Report Scope

Asia Pacific Hospital Bed Market Country and Regional Insights